Opinion: Abbott’s family tree is growing. Will its newest branch thrive like AbbVie?
Crain's Chicago Business
As Abbott's family tree continues to grow, the question arises: will its newest branch thrive like AbbVie? Navigating the complex landscape of the pharmaceutical industry, Abbott has shown resilience and adaptability, but can it maintain its momentum?
The pharmaceutical sector is a symphony of innovation and competition, where success often hinges on metamorphosis and indelible strategic decisions. Abbott has long been a testament to sustainability and growth, with its labyrinthine history reflecting the industry's evolution.
Will the newest addition to its portfolio, AbbVie, follow suit and revolutionize the market, or will it face challenges in bustling and vibrant competition? Only time will tell. However, one thing is certain: the future holds immense potential for Abbott and its diverse offerings.